These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia. Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665 [TBL] [Abstract][Full Text] [Related]
9. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis. Thompson PA; Edlund SA; Krolick KA Clin Immunol Immunopathol; 1995 Apr; 75(1):57-67. PubMed ID: 7882593 [TBL] [Abstract][Full Text] [Related]
10. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306 [TBL] [Abstract][Full Text] [Related]
11. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma. Li HL; Shi FD; Bai XF; Huang YM; van der Meide PH; Xiao BG; Link H Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006 [TBL] [Abstract][Full Text] [Related]
12. Antibody heterogeneity and specificity in myasthenia gravis. Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546 [TBL] [Abstract][Full Text] [Related]
13. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies. Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358 [TBL] [Abstract][Full Text] [Related]
14. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients. Eng H; Lefvert AK Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701 [TBL] [Abstract][Full Text] [Related]
15. Influence of immunological fine-specificity on the induction of experimental myasthenia gravis. Krolick KA; Thompson PA; Zoda TE; Yeh TM Ann N Y Acad Sci; 1993 Jun; 681():179-97. PubMed ID: 7689305 [No Abstract] [Full Text] [Related]
16. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis. Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222 [TBL] [Abstract][Full Text] [Related]
17. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Krolick KA; Yeh TM; Edlund SA Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801 [TBL] [Abstract][Full Text] [Related]
18. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Graus YM; De Baets MH Adv Neuroimmunol; 1994; 4(4):457-74. PubMed ID: 7719618 [No Abstract] [Full Text] [Related]
19. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors. Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141 [TBL] [Abstract][Full Text] [Related]
20. Suppression of antibody responses to the acetylcholine receptor by natural antibodies. Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]